- Intuit shares fell 9.8% after projecting slower sales growth and potential short-term trade-offs to boost TurboTax customers.
- Spyre Therapeutics stock slid 11% following trial results that caused the company to deprioritize a rheumatoid arthritis drug candidate.
- Zoom Communications and nCino both experienced stock declines after issuing third-quarter financial guidance that missed Wall Street expectations.